Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting.
暂无分享，去创建一个
G. di Perri | A. Calcagno | G. Cenderello | A. D’Avolio | D. Ripamonti | S. Rusconi | M. Rizzi | G. Orofino | L. Trentini | S. Bonora | V. Pirriatore | B. Salassa | L. Marinaro | C. Bramato